All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...711Next →

hiv & aids news selected from other sources

  • Conception
    How PrEP Helped One HIV-Negative Woman Become a Mother
    The Body | 1 hour ago

    All Poppy Morgan of San Francisco wanted was to see her husband, Ted, reflected in their child's face. Unfortunately, for many years, this could not be a reality. Ted was HIV positive, and Poppy could not find a way to conceive safely. After many disappointments, including a brief hope for sperm washing that was quickly dashed, Poppy found pre-exposure prophylaxis (PrEP).

  • Epidemiology
    Only three in 10 Americans have HIV under control: government report
    Reuters | 3 hours ago

    Just 30 percent of Americans living with HIV have the virus in check, putting others at risk of infection, U.S. health officials said yesterday. The report by the U.S. Centers for Disease Control and Prevention (CDC) found that 840,000 of the 1.2 million people infected with HIV in 2011 were not consistently taking anti-HIV drugs that keep the virus suppressed at very low levels.

  • Microbicides
    Looking to a New Era for Women's HIV Prevention: Zeda Rosenberg
    Huffington Post | 3 hours ago

    Zeda Rosenberg, Chief Executive Offiver of the International Partnership for Microbicides, says: "While there is much progress to celebrate in HIV treatment and prevention, protecting women remains a major challenge. AIDS is the number-one killer of women ages 15 to 44 worldwide. Women are biologically more vulnerable to infection and face deep-rooted gender inequities that increase their risk. In sub-Saharan Africa, where the epidemic has taken the greatest toll, young women are at least twice as likely to contract HIV as young men."

  • Hepatitis C transmission and prevention
    "Promising" results in Oxford trials of Hepatitis C vaccine
    Cherwell | 3 hours ago

    A new vaccine developed by researchers at the University of Oxford has generated a strong immune response against the Hepatitis C virus in human volunteers. The vaccine is the first Hepatitis C inoculation to reach this stage of clinical trials, and the results have been promising. The 15 healthy human volunteers who took part in the phase 1 safety trial all responded positively.The study found that after the second, booster inoculation, all 15 volunteers had large, broad and sustained T cells responses.

  • Epidemiology and behaviour
    Hong Kong's new HIV cases hit record high with 195 people diagnosed in Q3
    South China Morning Post | 4 hours ago

    A total of 195 new HIV cases were reported Hong Kong in the third quarter of the year, the highest number ever in a single quarter, Hong Kong's Centre for Health Protection said yesterday, while a separate survey found that the infection rate among gay men had risen almost two percentage points. More than 85 per cent of new HIV cases were in men, most aged from 20 to 29. HIV prevalence in gay men has risen from 4.1% to 5.9% - a 44% increase in a single year - though this new estimate may partly be due to more people coming forward to be tested.

  • Epidemiology and behaviour
    Greece: new HIV cases fall in 2013 due to halving of infections in injecting drug users

    Health authorities in Greece say the number of HIV infections fell in 2013 for the first time since the start of the financial crisis. In its annual report issued Tuesday, Greece's Center for Disease Control and Prevention said the number of new infections nationwide fell by 20%, from 920 last year from 1,188 in 2012. This is largely due to a 52% decline in infections in people who inject drugs after a sharp spike in infections in 2012.

  • New and experimental HIV treatments
    European Commission approves Rezolsta ® , a new once - daily , fixed - dose HIV therapy combining darunavir and cobicistat
    Janssen | 18 hours ago

    Janssen-Cilag International NV (Janssen) today announced that the European Commission (EC) has approved the use of REZOLSTA ® (darunavir/cobicistat) in combination with other antiretroviral (ARV) medicinal products for the treatment of human immunodeficiency virus - 1 (HIV - 1) infection in adults aged 18 years or older. "REZOLSTA ® eliminates the need to take a boosting agent in a separate tablet with once - daily darunavir, reducing the pill burden for patients," said Christiane Moecklinghoff, M.D Ph.D, Medical Director, Virology, Janssen EMEA.

  • Injecting drug use
    Why the UK’s drug strategy should remain a Home Office responsibility
    The Guardian | 20 hours ago

    Handing the reins to the Department of Health might seem a liberal-minded approach, but it could mean less is spent on treatment. Drug use simply doesn’t cause as much ill-health as other risky behaviours, so isn't prioritised by health officials. But it is seen as a major cause of crime.

  • Testing policies and guidelines
    Sexual health charity launches webtool to increase HIV testing in primary care
    MEDFASH press release | 21 hours ago

    With a quarter of the estimated 108,000 people living with HIV in the UK still going undiagnosed, MEDFASH has developed HIV Testing in Practice (HIV TIPs), an online educational tool, to help increase rates of HIV diagnosis in primary care. Launched in National HIV Testing Week, the interactive webtool will enable GPs, practice nurses and their teams to raise their knowledge of HIV and enhance their confidence in offering HIV testing.

  • Starting treatment
    START Study Could Change How We Look at HIV Treatment, and HIV Itself
    The Body | 25 November 2014

    Have you heard of the START (Strategic Timing of Antiretroviral Treatment) study? In my opinion, it is probably the most important study currently running. It generates strong views, both for and against initiating antiretroviral therapy early, but the results are likely to be surprising.

← First12345...973Next →

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.